First human test for new inhaled medicine begins

NCT ID NCT07301203

Recruiting now Knowledge-focused Sponsor: Beijing Tide Pharmaceutical Co., Ltd Source: ClinicalTrials.gov ↗

Summary

This is an early safety study for a new inhaled medication called CPD704. It will test single and repeated doses in 90 healthy Chinese adults to see how safe it is and how the body processes it. The main goal is to check for side effects and measure drug levels in the blood.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

China-Japan Friendship Hospital
RECRUITING

Beijing, Beijing Municipality, 100020, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HEALTHY HEALTHY PARTICIPANTS